Advertisements


Nektar reports 48% overall response rate in urothelial cancer for NKTR-214 combo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Nektar bladder cancer response rate exceeded expectation, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Nektar Therapeutics Tumbles To 2-Year Low On Q2 Revenue Miss, Manufacturing Issues With Cancer Drug

Nektar Therapeutics (NASDAQ: NKTR) shares were plummeting to a two-year low Friday following the release .....»»

Category: earningsSource: benzingaAug 9th, 2019

Nektar Therapeutics Tumbles To 2-Year Low On Q2 Revenue Miss, Manufacturing Issues With Cancer Drug

Nektar Therapeutics (NASDAQ: NKTR) shares were plummeting to a two-year low Friday following the release of its quarterly results the prior afternoon, wiping away roughly $1.9 billion of its marke read more.....»»

Category: blogSource: benzingaAug 9th, 2019

Rexahn reports overall response rate of 23% in Phase 2a study of RX-3117

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2019

Dynavax abstract shows 40% response rate in head and neck cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Nektar Starts Phase I/II Combo for Advanced Solid Tumors

Nektar (NKTR) initiates dosing in a phase I/II study, evaluating the combination of its two novel immuno-oncology agent.....»»

Category: worldSource: nytApr 12th, 2018

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results........»»

Category: blogSource: 247wallstJun 4th, 2018

We just got a lot of updates on the state of cancer treatments — here are the winners and losers (BLUE, NKTR, LOXO, MRK, BMY)

Over the weekend at the American Society of Clinical Oncologists meeting, a lot of updates and new data were presented.  It sent stocks all over the place Monday with the biggest movers being Bristol-Myers Squibb, Nektar, Loxo and Bluebird bi.....»»

Category: topSource: businessinsiderJun 4th, 2018

Nektar Plummets Amid Concern Over Cancer-Drug Trial Results

Nektar Therapeutics lost a third of its value in Monday trading after response rates in melanoma and kidney cancer patients decreased in a mid-stage trial of the company’s cancer drug in combination with Bristol-Myers Squibb Co.’s Opdivo......»»

Category: topSource: moneycentralJun 4th, 2018

Iovance reports objective response rate of 37% in Cohort 2 of C-144-01 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Iovance reports 27% objective response rate in study of cervical carcinoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Ruth Bader Ginsburg Treated For Pancreatic Cancer

Ruth Bader Ginsburg, the 86-year-old Supreme Court Justice, has been treated for a tumor on her pancreas, according to media reports. The long-time SCOTUS.....»»

Category: blogSource: zerohedge12 hr. 37 min. ago

European shares steady on upbeat PMI data

European shares traded close to flat on Thursday as upbeat surveys on Germany and the euro zone offset signs that U.S. policymakers had not intended to start a cycle of interest rate cuts with last month's move. Francis Maguire reports......»»

Category: videoSource: reutersAug 22nd, 2019

Karyopharm selinexor phase 2b data published in NEJM saw 26% response rate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2019

Aflac cancer insurance policies mis-sold by Japan Post, The Mainichi reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2019

AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study

AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»

Category: blogSource: benzingaAug 21st, 2019

Cancer Genetics reports Q2 cont. ops. EPS (1c) vs. (3c) last year

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 20th, 2019

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

RUTHERFORD, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (NASDAQ:CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic, .....»»

Category: earningsSource: benzingaAug 20th, 2019

Citi reports July credit loss rate 2.91% vs. 2.56% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019

American Express reports July net write-off rate 2.2% vs. 2.2% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019